Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE COMPRISING LYSOPHOSPHOLIPID
Document Type and Number:
WIPO Patent Application WO/2023/068504
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for the prevention or treatment of a metabolic disease, comprising lysophospholipid. The pharmaceutical composition of the present invention promotes the PKA signaling pathway and upregulates lipolysis and mitochondrial oxidative metabolism, and thus can prevent or treat a metabolic disease such as obesity or diabetes.
More Like This:
Inventors:
LEE YUN HEE (KR)
CHO YOON KEUN (KR)
IM HYEON YEONG (KR)
LEE SU MIN (KR)
CHO YOON KEUN (KR)
IM HYEON YEONG (KR)
LEE SU MIN (KR)
Application Number:
PCT/KR2022/011626
Publication Date:
April 27, 2023
Filing Date:
August 05, 2022
Export Citation:
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
International Classes:
A61K31/685; A23L33/10; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12
Foreign References:
KR20080019050A | 2008-02-29 | |||
KR20120061016A | 2012-06-12 | |||
KR20130099754A | 2013-09-06 | |||
US6846801B1 | 2005-01-25 |
Other References:
SOGA, T. OHISHI, T. MATSUI, T. SAITO, T. MATSUMOTO, M. TAKASAKI, J. MATSUMOTO, S.-I. KAMOHARA, M. HIYAMA, H. YOS: "Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 326, no. 4, 28 January 2005 (2005-01-28), Amsterdam NL , pages 744 - 751, XP004682876, ISSN: 0006-291X, DOI: 10.1016/j.bbrc.2004.11.120
Attorney, Agent or Firm:
LEECHAE INTELLECTUAL PROPERTY (KR)
Download PDF: